ITM Receives German Medical Award 2019 for the Most Innovative Product
ITM wins German Medical Award in the category “Medical Innovation Product” for outstanding patient benefit and advanced treatment approach with…
Pharmaceuticals, Biotechnology and Life Sciences
ITM wins German Medical Award in the category “Medical Innovation Product” for outstanding patient benefit and advanced treatment approach with…
BUFFALO GROVE, Ill.–(BUSINESS WIRE)–Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments…
First clinical study in healthy subjects of a direct-to-lung, Thin Film Freezing (TFF) dry-powder formulation Invasive Pulmonary Aspergillosis is a…
Appoints Laurent Chardonnet as Chief Financial Officer Promotes Heidy King-Jones to General Counsel CAMBRIDGE, Mass.–(BUSINESS WIRE)–Axcella Health (Nasdaq: AXLA), a…
JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today the early tender results in connection with its…
Ferring launches new company FerGene, with a focus on the global development and US commercialization of nadofaragene firadenovec, for high-grade,…
– Approval of Supplemental New Drug Submission for ADCETRIS in Combination with CHP Chemotherapy in Frontline CD30-Expressing Peripheral T-Cell Lymphoma…
NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company pioneering new innovations in neuromodulator products for aesthetic and therapeutic…
– Globally Recognized Innovator Played a Key Role in the Discovery and Vector Development of New AAV Serotypes – NEW…
WILMINGTON, Del.–(BUSINESS WIRE)–$INCY #ASH19–Incyte (Nasdaq:INCY) announces that numerous abstracts, including data from its clinical development programs for ruxolitinib (Jakafi®), itacitinib…